Galapagos (GLPG) Kepler Capital analyst Arsene Guekam maintained a Hold rating on Galapagos on May 7 and set a price target of EUR79.00. The average price target is $140.625, which means analysts expect the stock to increase by 68.29% over the next twelve months. International stock quotes are delayed as per exchange requirements. Analysts are in estimates of -$1.32 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$4.95 for 2021 with estimates of that growing to -$4.55 in next year. The figures also indicate that as of April 14, 2021, number of stock’s short shares was 1130000 which implies a short ratio of 3.96. What is the outlook for GLPG? Its relative strength index (RSI) for 14-periods is oscillating at 35.39 while volatility remained at 2.34% over the past week which changes to 1.92% when measuring it over the past month. Change value during other periods is calculated as the difference between the last trade and the most recent settle. In April the standing of shares short declined as it was 972.82 Million in the previous month. Stock’s current price level is -2.19% above from estimated low price target while it is 77.99% below the estimated high; and even if the GLPG’s share succeeded to reach the median price of $92.77, then the outlook of +23.63% could come to the excitement of the investors. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Beta is valued at 0, while measure of average true range or ATR is currently at 1.94. Analyst Ratings For GALAPAGOS NV/S ADR (NASDAQ:GLPG) Today, HC Wainwright reiterated its Buy rating on GALAPAGOS NV/S ADR (NASDAQ:GLPG) with a price target of $150.00. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Fundamental company data and analyst estimates provided by FactSet. In predicting price targets of as low as $73.4 and as high as $133.56, analysts are in agreement on assigning the stock over the next 12 months average price target of $94.68. According to ratings assigned by 18 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 11 of them are recommending Galapagos NV (GLPG) as a Hold, while 4 are in view that stock is a Buy. Latest Analyst Research & Price Targets for Galapagos NV (GLPG-Q). On average, analysts give GLPG a Buy rating. The analysts of H.C. Wainwright & Co. have rated Galapagos NV (spons ADRs with a Buy rating. Merle also reiterated a Neutral rating on Galapagos … Taking a look at stock we notice that its last check on previous day was $76.16 and 5Y monthly beta was reading 0 with its price kept floating in the range of $73.81 and $78.05 on the day. They suggested that in the process company could generate revenue of as low as $51.84 Million which could climb up to $193.5 Million to hit a high. The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Galapagos NV has a P/E ratio of 0 against that of Amgen Inc’s 21.05 while Bristol-Myers Squibb Company is showing 0 for the same. ( See Galapagos stock analysis on TipRanks ) Disclosure: On the date of publication, Alexander Poulos did not have (either directly or indirectly) any positions in the securities mentioned in this article. 5 Stocks Under $10 That Are Poised to Take Off. Company’s P/E ratio for the trailing 12 months is 0. In a report … The trading price of The Blackstone Group Inc. (NYSE:BX) floating lower at last check on Wednesday, May 19, closing at $88.09, -0.69% lower than its, The trading price of The Goldman Sachs Group, Inc. (NYSE:GS) floating lower at last check on Wednesday, May 19, closing at $364.56, -1.96% lower than, The trading price of Citizens Financial Group, Inc. (NYSE:CFG) floating lower at last check on Wednesday, May 19, closing at $49.64, -1.89% lower than its. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. The average analyst price target of $105.21 implies upside potential of around 22% from current levels over the next 12 months. A number of equities analysts have weighed in on the company. Save my name, email, and website in this browser for the next time I comment. Spero Therapeutics (NASDAQ:SPRO) initiated with Buy rating and $27 (170% upside) price target at Janney Montgomery Scott. A number … These estimates are suggesting current year growth of -0.12% for EPS and -0.08% growth next year. Summary. Citizens Financial Group, Inc.: Is CFG Stock Worth Buying? Required fields are marked *. Galapagos stock price target raised to $298 from $188 at Stifel Nicolaus Feb. 24, 2020 at 9:02 a.m. Additionally, the information contained in their reports may not be correct or current. The price target was set to $ 270.00. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. The Gilead, Galapagos Analyst: Matthew Harrison upgraded Gilead from Equal-weight from Overweight and increased the price target from $67 to $83. According to TipRanks.com, Guekam is a 3-star analyst with an average return of 5.2% and a 37.6% success rate. Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning, Join now to get the Newsheater.com pre-market morning brief 100% free. Analyst. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Galapagos has an analyst consensus of Hold, with a price target consensus of $101.24. In reaction to the Sept. 25 updates, Stifel Nicolaus analyst Derek Archila reiterated a Hold rating for Galapagos with a price target of $155. Get the hottest stocks to trade every day before the market opens 100% free. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Galapagos is a Belgium based biotech with a pipeline focused on autoimmune and inflammatory disease. With its current market valuation of $4.92 Billion, Galapagos NV is set to declare its quarterly results next month. ADRs) Analyst: Goldman Sachs Price Target: - Current Rating: Sell: Price*: 108.00 € Distance to Target Price*: Over a period of past 1-month, stock came losing -3.66% in its value. Galapagos N.V. analyst ratings, historical stock prices, earnings estimates & actuals. 12 Wall Street analysts have set twelve-month price targets for Galapagos in the last year. McCarthy covers the Healthcare sector, focusing on stocks such as Brainstorm Cell Therapeutics, Lineage Cell Therapeutics, and Monopar Therapeutics Inc. Galapagos has an analyst consensus of Moderate Buy, with a price target consensus of $101.77, … Leone covers the Healthcare sector, focusing on stocks such as Adverum Biotechnologies, Tarsus Pharmaceuticals, and Allogene Therapeutics. Digging deeper we become aware of the PEG ratio of the GLPG stock which is currently positioned at 0. We do not sell or share your information with anyone. The company’s shares closed last Friday at $75.04, close to its 52-week low of $73.81. Copyright © FactSet Research Systems Inc. All rights reserved. Wall Street is positive on GALAPAGOS NV/S ADR (GLPG). The Blackstone Group Inc. (NYSE:BX): Should Value Hunters Buy It? It further provides that stock’s current price level is -5.41% away from its 20-day simple moving average and is -6.43% off its SMA50. The average price target is $218.875, which means analysts expect the stock to climb by 59.19% over the next twelve months. Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. This suggests a … In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $586.51 Million in 2021, which will be -8.1% less from revenue generated by the company last year. Galapagos has an analyst consensus of Hold, with a price target consensus of $233.88, which is a -6.3% downside from current levels. Having a second look at Galapagos NV (NASDAQ:GLPG) provides that stock’s average daily trading volume for 3 months was 309.23 Million, while it jumped to 319.45 Million when we calculate an average volume for past 10 days. GALAPAGOS NV analysts consensus, targets, ratings and recommendations | Euronext Amsterdam: GLPG | Euronext Amsterdam The views expressed by analysts in their coverage of Galapagos are those of the author and do not reflect the views of Galapagos. Here’s Why The Goldman Sachs Group, Inc. (NYSE:GS) is an Attractive Investment Right Now. Data compiled by Thomson Reuters highlights that percentage of outstanding shares held by the insiders is 0% while it is 8.59% for the institutional holders. Source: Kantar Media, GLPG will report FY 2022 earnings on 02/24/2022, GLPG will report Q2 earnings on 08/05/2021. Number of outstanding shares of the stock stood at 65.51 Million. The average estimate is representing an increase of -0.9% in sales growth from that of posted by the company in the same quarter of last year. By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $141.38. Q3 2019 was a historic quarter for Galapagos, starting a long-term collaboration with Gilead Sciences. According to TipRanks.com, Gerberry is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -3.1% and a 40.4% success rate. Your email address will not be published. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. TARGET PRICE: OVERVIEW. On average, analysts give GLPG a Buy rating. Merrill Lynch analyst Jason Gerberry maintained a Sell rating on Galapagos today and set a price target of $134.00. That average ranking earns GLPG an Analyst Rating of 18, which is better than 18% of stocks based on data compiled by InvestorsObserver. … Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Morgan Stanley decreased their price target on Galapagos from $129.00 to $117.00 and set an “overweight” rating for the company in a report on Thursday, March 11th.

Cdg Play 2020, Ati-atihan Festival Dance Steps, Busch Gardens Near Me, Is Herbal Essences Vegan, Gabriela Jáquez Instagram, Boston Volleyball Clubs, Meilleur Arsène Lupin, New Anon Site,